newsfilter
← Latest News
GlobeNewswire·

Syndax Announces Private Placement of $250.0 Million of Convertible Senior Notes

NEW YORK, June 04, 2026 (GLOBE NEWSWIRE) -- Syndax Pharmaceuticals, Inc. ("Syndax") (NASDAQ:SNDX), a commercial-stage biopharmaceutical company advancing innovative cancer therapies, has entered into privately